Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy Guggenheim

Start price
€46.50
23.12.25 / 50%
Target price
-
23.12.26
Performance (%)
3.55%
Price
€48.15
15:42
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 3.55%. This prediction currently runs until 23.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w
Bristol-Myers Squibb 4.145%
iShares Core DAX® 2.659%
iShares Nasdaq 100 0.916%
iShares Nikkei 225® 2.426%
iShares S&P 500 1.230%

Comments by Guggenheim for this prediction

In the thread Bristol-Myers Squibb diskutieren

Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for BMY provided by MarketBeat